|
06-2032
|
INSiGHTS - Innovative Next Steps in Gaining Health Improvements Through Translational Science
INSiGHTS - Innovative Next Steps in Gaining Health Improvements Through Translational Science
|
|
08-2029
|
The role of adoptive cellular therapy on myeloid-derived suppressor cell depletion in glioma
The role of adoptive cellular therapy on myeloid-derived suppressor cell depletion in glioma
|
|
07-2029
|
Nanotechnology enabled quantitative imaging of dendritic cell anti-cancer vaccines
Nanotechnology enabled quantitative imaging of dendritic cell anti-cancer vaccines
|
|
07-2029
|
Addressing tumor heterogeneity in pediatric gliomas with precision adoptive T cell therapy
Addressing tumor heterogeneity in pediatric gliomas with precision adoptive T cell therapy
|
|
05-2028
|
CHAMP1ON - Combinatorial Hematopoietic Stem Cell And Monoclonal Antibody PD-1 Blockade Phase 1 "Window of Opportunity" Trial for RecurreNt Pediatric High-Grade Glioma
CHAMP1ON - Combinatorial Hematopoietic Stem Cell And Monoclonal Antibody PD-1 Blockade Phase 1 "Window of Opportunity" Trial for RecurreNt Pediatric High-Grade Glioma
|
|
07-2027
|
Nanoparticles to Track T Cell Immunotherapy Using Magnetic Particle Imaging
Nanoparticles to Track T Cell Immunotherapy Using Magnetic Particle Imaging
|
|
06-2027
|
Rally Young Investigator Grant: Focused ultrasound delivery of personalized nanoparticle vaccines for brain
Rally Young Investigator Grant: Focused ultrasound delivery of personalized nanoparticle vaccines for brain
|
|
05-2027
|
UF Health Cancer Center Support Grant
UF Health Cancer Center Support Grant
|
|
03-2027
|
Next-generation mRNA vaccine for glioblastoma
Next-generation mRNA vaccine for glioblastoma
|
|
02-2027
|
Adoptive Cellular Therapy Targeting Recurrent/Progressive Oligodendroglioma
Adoptive Cellular Therapy Targeting Recurrent/Progressive Oligodendroglioma
|
|
12-2026
|
Unlocking CAR T cells Activity Against Metastatic Osteosarcoma Using Systemic RNA Vaccination
Unlocking CAR T cells Activity Against Metastatic Osteosarcoma Using Systemic RNA Vaccination
|
|
12-2026
|
Combining Epigenetic Therapy and Immunotherapy to Target Group 4 Medulloblastoma
Combining Epigenetic Therapy and Immunotherapy to Target Group 4 Medulloblastoma
|
|
09-2026
|
A Safety and Preliminary Efficacy trial of MK-3475 (pembrolizumab; anti-PD-1) in Children with recurrent, progressive or refractory high-grade gliomas (HGG) and DIPGs
A Safety and Preliminary Efficacy trial of MK-3475 (pembrolizumab; anti-PD-1) in Children with recurrent, progressive or refractory high-grade gliomas (HGG) and DIPGs
|
|
08-2026
|
Overcoming Immune Checkpoint Blockade Resistance in Glioblastoma with a Novel Stem Cell Biotherapeutic
Overcoming Immune Checkpoint Blockade Resistance in Glioblastoma with a Novel Stem Cell Biotherapeutic
|
|
07-2026
|
Addressing tumor heterogeneity in pediatric gliomas with precision adoptive T cell therapy
Addressing tumor heterogeneity in pediatric gliomas with precision adoptive T cell therapy
|
|
07-2026
|
Combining Epigenetic Therapy and Immunotherapy to Target Group 4 Medulloblastoma
Combining Epigenetic Therapy and Immunotherapy to Target Group 4 Medulloblastoma
|
|
06-2026
|
COM CTSI Institutional Support
COM CTSI Institutional Support
|
|
06-2026
|
UFR CTSI Instituitonal Support
UFR CTSI Instituitonal Support
|
|
05-2026
|
F30 (Francis) Thymic PD-1 blockade mediates the anti-tumor immune response in pediatric high-grade glioma
F30 (Francis) Thymic PD-1 blockade mediates the anti-tumor immune response in pediatric high-grade glioma
|
|
08-2025
|
RNA-nanoparticle vaccines for pediatric high-grade glioma
RNA-nanoparticle vaccines for pediatric high-grade glioma
|
|
06-2025
|
Together: Transforming and Translating Discovery to Improve Health
Together: Transforming and Translating Discovery to Improve Health
|
|
06-2025
|
Florida Center for Brain Tumor Research
Florida Center for Brain Tumor Research
|
|
05-2025
|
Nanoparticles for In Vivo Labeling of T Cells During Cancer Immunotherapy
Nanoparticles for In Vivo Labeling of T Cells During Cancer Immunotherapy
|
|
04-2025
|
Combining Epigenetic Therapy and Immunotherapy to Target Group 4 Medulloblastoma
Combining Epigenetic Therapy and Immunotherapy to Target Group 4 Medulloblastoma
|
|
03-2025
|
Unlocking CAR T cell efficacy against osteosarcoma using adjuvant RNA vaccine
Unlocking CAR T cell efficacy against osteosarcoma using adjuvant RNA vaccine
|
|
10-2024
|
Curis #3
Curis #3
|
|
10-2024
|
Novel adoptive T cell therapy approaches targeting infiltrating tumor cells causing recurrence of high grade glioma
Novel adoptive T cell therapy approaches targeting infiltrating tumor cells causing recurrence of high grade glioma
|
|
08-2024
|
Targeting CCR2-expressing myeloid cells to overcome immune checkpoint inhibitor resistance in glioma
Targeting CCR2-expressing myeloid cells to overcome immune checkpoint inhibitor resistance in glioma
|
|
06-2024
|
Core Clinical Consortium for Blood and Marrow Transplant Clinical Trials Network
Core Clinical Consortium for Blood and Marrow Transplant Clinical Trials Network
|
|
06-2024
|
HSC COM Matching Commitment
HSC COM Matching Commitment
|
|
06-2024
|
COM CTSI Institutional Support
COM CTSI Institutional Support
|
|
06-2024
|
OoR Matching Support for CTSI
OoR Matching Support for CTSI
|
|
06-2024
|
Together: Transforming and Translating Discovery to Improve Health
Together: Transforming and Translating Discovery to Improve Health
|
|
05-2024
|
Together: Transforming and Translating Discovery to Improve Health
Together: Transforming and Translating Discovery to Improve Health
|
|
04-2024
|
Combination Immunotherapy for Pediatric Brain Tumors
Combination Immunotherapy for Pediatric Brain Tumors
|
|
03-2024
|
Selective expansion of neoantigen-specific T cells targeting medulloblastoma
Selective expansion of neoantigen-specific T cells targeting medulloblastoma
|
|
12-2023
|
NSU Immunomix GMP
NSU Immunomix GMP
|
|
12-2023
|
Phase I - Recombinant AAV biotherapy for the treatment of Diffuse Midline Glioma (DMG) malignant brain tumors
Phase I - Recombinant AAV biotherapy for the treatment of Diffuse Midline Glioma (DMG) malignant brain tumors
|
|
11-2023
|
Multi-center phase I study evaluating lipid-nanoparticle vaccines against pediatric high-grade glioma
Multi-center phase I study evaluating lipid-nanoparticle vaccines against pediatric high-grade glioma
|
|
08-2023
|
Targeted STAT3 inhibition impairs MDSC mobilization and recruitment in glioblastoma
Targeted STAT3 inhibition impairs MDSC mobilization and recruitment in glioblastoma
|
|
08-2023
|
Targeting Primary CNS B cell Lymphoma Unique Antigens with Novel Immunotherapy
Targeting Primary CNS B cell Lymphoma Unique Antigens with Novel Immunotherapy
|
|
06-2023
|
Admin Diversity Supp (Mailhot)-Together Transforming and Translating Discovery to Improve Health
Admin Diversity Supp (Mailhot)-Together Transforming and Translating Discovery to Improve Health
|
|
06-2023
|
Targeting IL-6 for Vasospasm Treatment following Subarachnoid Hemorrhage: the Microglia Response
Targeting IL-6 for Vasospasm Treatment following Subarachnoid Hemorrhage: the Microglia Response
|
|
06-2023
|
Rosen Foundation Funds
Rosen Foundation Funds
|
|
06-2023
|
A 3D Tissue Map of the Human Lymphatic System
A 3D Tissue Map of the Human Lymphatic System
|
|
06-2023
|
Support for brain tumor research
Support for brain tumor research
|
|
06-2023
|
DENDRITIC CELL (DC) AND TUMOR-SPECIFIC CYTOTOXIC T CELL (CTL) GENERATION PROTOCOL FROM HEALTHY VOLUNTEERS AND PATIENTS WITH MALIGNANT BRIAN TUMORS
DENDRITIC CELL (DC) AND TUMOR-SPECIFIC CYTOTOXIC T CELL (CTL) GENERATION PROTOCOL FROM HEALTHY VOLUNTEERS AND PATIENTS WITH MALIGNANT BRIAN TUMORS
|
|
04-2023
|
Pan-Neoantigen Targeted RNA-nanoparticles for Recurrent Pulmonary Osteosarcoma
Pan-Neoantigen Targeted RNA-nanoparticles for Recurrent Pulmonary Osteosarcoma
|
|
02-2023
|
Optimizing adoptive cell therapy for pediatric brain tumors
Optimizing adoptive cell therapy for pediatric brain tumors
|
|
02-2023
|
Expansion of The Sunshine Project
Expansion of The Sunshine Project
|
|
12-2022
|
Neoadjuvant Combination Immunotherapy for Glioblastoma
Neoadjuvant Combination Immunotherapy for Glioblastoma
|
|
11-2022
|
Leveraging Temozolomide to Improve Treatment Efficacy of Immune Checkpoint Blockade in Glioblastoma
Leveraging Temozolomide to Improve Treatment Efficacy of Immune Checkpoint Blockade in Glioblastoma
|
|
11-2022
|
Selective Expansion of Neoantigen-Specific T Cells Targeting Medulloblastoma
Selective Expansion of Neoantigen-Specific T Cells Targeting Medulloblastoma
|
|
09-2022
|
Optimizing Adoptive Cell Therapy for Glioblastoma Using Novel Noninvasive Magnetic Particle Imaging
Optimizing Adoptive Cell Therapy for Glioblastoma Using Novel Noninvasive Magnetic Particle Imaging
|
|
08-2022
|
Immunologic Targeting of Developmentally-Regulated Antigens for the Treatment of High-Risk Medulloblastoma
Immunologic Targeting of Developmentally-Regulated Antigens for the Treatment of High-Risk Medulloblastoma
|
|
07-2022
|
Wells Center for Brain Tumor Therapy
Wells Center for Brain Tumor Therapy
|
|
06-2022
|
Examination of CNS Uptake
Examination of CNS Uptake
|
|
06-2022
|
NPCF excellence award
NPCF excellence award
|
|
05-2022
|
Developing a Sustainable, Resilient Clinical Research Professionals Workforce through Team Science and Mentoring
Developing a Sustainable, Resilient Clinical Research Professionals Workforce through Team Science and Mentoring
|
|
03-2022
|
Together Transforming and Translating Discovery to Improve Health
Together Transforming and Translating Discovery to Improve Health
|
|
03-2022
|
The STAT3 Inhibitor LLL12B Regulates Immune Activation in Medulloblastoma
The STAT3 Inhibitor LLL12B Regulates Immune Activation in Medulloblastoma
|
|
03-2022
|
Curis Phase II - Examination of CNS Uptake
Curis Phase II - Examination of CNS Uptake
|
|
12-2021
|
Legacy Foundation
Legacy Foundation
|
|
11-2021
|
A randomized study to assess the efficacy of SARS-CoV-2 EUA vaccine in preventing SARS-CoV-2 infection and viral shedding in US college students
A randomized study to assess the efficacy of SARS-CoV-2 EUA vaccine in preventing SARS-CoV-2 infection and viral shedding in US college students
|
|
09-2021
|
Immunotherapeutic targeting of osteosarcoma with nanoparticle vaccines
Immunotherapeutic targeting of osteosarcoma with nanoparticle vaccines
|
|
08-2021
|
Harnessing the Immunologic Capacity of RNA-nanoparticle Vaccines Targeting Glioblastoma
Harnessing the Immunologic Capacity of RNA-nanoparticle Vaccines Targeting Glioblastoma
|
|
08-2021
|
A vaccine strategy to overcome treatment induced immunosuppression in glioma
A vaccine strategy to overcome treatment induced immunosuppression in glioma
|
|
07-2021
|
Reprogramming Host Immunity in Treatment-Resistant Head and Neck Cancer Using Personalized RNA Nanoparticle Vaccines
Reprogramming Host Immunity in Treatment-Resistant Head and Neck Cancer Using Personalized RNA Nanoparticle Vaccines
|
|
07-2021
|
Efficacy of Dendritic Cell Vaccines Targeting CMV in Glioblastoma (phase 2 DC vaccine)
Efficacy of Dendritic Cell Vaccines Targeting CMV in Glioblastoma (phase 2 DC vaccine)
|
|
07-2021
|
White House Study: Evaluate COVID-19 Detection Technology
White House Study: Evaluate COVID-19 Detection Technology
|
|
07-2021
|
Remodeling Host Immunity in Oral Cancer with Personalized RNA Nanoparticle Vaccines
Remodeling Host Immunity in Oral Cancer with Personalized RNA Nanoparticle Vaccines
|
|
06-2021
|
OoR CTSI Institutional Matching Support
OoR CTSI Institutional Matching Support
|
|
06-2021
|
Together: Transforming and Translating Discovery to Improve Health
Together: Transforming and Translating Discovery to Improve Health
|
|
06-2021
|
MIsc. Donors
MIsc. Donors
|
|
06-2021
|
ABC2 funding for Florida Center for Brain Tumor Research grant for 2015 grantees
ABC2 funding for Florida Center for Brain Tumor Research grant for 2015 grantees
|
|
06-2021
|
CTSI Institutional Support
CTSI Institutional Support
|
|
06-2021
|
Adoptive Cellular Therapy following Dose-Intensified Temozolomide in Newly-diagnosed Pediatric High-grade Gliomas (Phase I)
Adoptive Cellular Therapy following Dose-Intensified Temozolomide in Newly-diagnosed Pediatric High-grade Gliomas (Phase I)
|
|
06-2021
|
Florida Center for Brain Tumor Research - Statewide Brain Tumor Registry Program at the McKnight Brain Institute
Florida Center for Brain Tumor Research - Statewide Brain Tumor Registry Program at the McKnight Brain Institute
|
|
06-2021
|
CXCL9 AAV-engineered neutrophils as a novel Trojan Horse cellular therapy to promote T cell chemotaxis in GBM
CXCL9 AAV-engineered neutrophils as a novel Trojan Horse cellular therapy to promote T cell chemotaxis in GBM
|
|
05-2021
|
Enhancing Adoptive Immunotherapy Targeting Pediatric High-Grade Gliomas
Enhancing Adoptive Immunotherapy Targeting Pediatric High-Grade Gliomas
|
|
05-2021
|
Engineering RNA-nanoparticles to enhance dendritic cell mediated treatment of glioblastoma
Engineering RNA-nanoparticles to enhance dendritic cell mediated treatment of glioblastoma
|
|
03-2021
|
Pediatric Brain Tumor Consortium
Pediatric Brain Tumor Consortium
|
|
12-2020
|
CTSI
CTSI
|
|
09-2020
|
RNA-nanoparticles targeting H3.3 K27M epitopes in diffuse intrinsic pontine glioma
RNA-nanoparticles targeting H3.3 K27M epitopes in diffuse intrinsic pontine glioma
|
|
07-2020
|
Newly-Diagnosed Brain Stem Gliomas Treated with Adoptive Cellular Therapy During Recovery from Focal Radiotherapy Alone or Radiotherapy and Dose-intensified Temozolomide
Newly-Diagnosed Brain Stem Gliomas Treated with Adoptive Cellular Therapy During Recovery from Focal Radiotherapy Alone or Radiotherapy and Dose-intensified Temozolomide
|
|
06-2020
|
Together: Transforming and Translating Discovery to Improve Health
Together: Transforming and Translating Discovery to Improve Health
|
|
06-2020
|
Newly-Diagnosed Brain Stem Gliomas Treated with Adoptive Cellular Therapy during Recovery from Focal Radiotherapy Alone or Radiotherapy and Dose-intensified Temozolomide
Newly-Diagnosed Brain Stem Gliomas Treated with Adoptive Cellular Therapy during Recovery from Focal Radiotherapy Alone or Radiotherapy and Dose-intensified Temozolomide
|
|
06-2020
|
Endowed Research Chair
Endowed Research Chair
|
|
03-2020
|
Pediatric Brain Tumor Consortium
Pediatric Brain Tumor Consortium
|
|
01-2020
|
Immunologic targeting of molecular subtypes of medulloblastoma
Immunologic targeting of molecular subtypes of medulloblastoma
|
|
12-2019
|
Re-MATCH: Recurrent Medulloblastoma and Primitive Neuroectodermal Tumor Adoptive Cell Therapy During Recovery from Myeloablative Chemotherapy and Hematopoietic Stem Cell Transplantation
Re-MATCH: Recurrent Medulloblastoma and Primitive Neuroectodermal Tumor Adoptive Cell Therapy During Recovery from Myeloablative Chemotherapy and Hematopoietic Stem Cell Transplantation
|
|
07-2019
|
Engineering a Clinically Accessible Biomarker for Glioblastoma Immunotherapy
Engineering a Clinically Accessible Biomarker for Glioblastoma Immunotherapy
|
|
06-2019
|
FIorida Center for Brain Tumor Research (FCBTR)
FIorida Center for Brain Tumor Research (FCBTR)
|
|
06-2019
|
Support for Research in Regenerative Medicine and Brain Cancers
Support for Research in Regenerative Medicine and Brain Cancers
|
|
03-2019
|
A Phase I Trial of Pomalidomide for children with recurrent, progressive or refractory CNS tumors
A Phase I Trial of Pomalidomide for children with recurrent, progressive or refractory CNS tumors
|
|
02-2019
|
Support of Research at the McKnight Brain Institute
Support of Research at the McKnight Brain Institute
|
|
01-2019
|
Engineering a clinically accessible biomarker for glioblastoma immunotherapy
Engineering a clinically accessible biomarker for glioblastoma immunotherapy
|
|
06-2018
|
Florida Center for Brain Tumor Research (FCBTR) Grant for 2016
Florida Center for Brain Tumor Research (FCBTR) Grant for 2016
|
|
12-2017
|
Finding the Genes that Predispose to Trigeminal Neuralgia
Finding the Genes that Predispose to Trigeminal Neuralgia
|
|
06-2017
|
Expedited: Resident Fatigue as a Function of Shift Length: Assessing Resident Neurocognitive Function at Varying Time Intervals
Expedited: Resident Fatigue as a Function of Shift Length: Assessing Resident Neurocognitive Function at Varying Time Intervals
|
|
05-2017
|
Therapeutic Targeting of immune metabolism
Therapeutic Targeting of immune metabolism
|
|
08-2016
|
Establish comparative immunogenicity of LAMP modified pp65 and mTERT using DNA based vaccines, RNA electroporated DCs, and RNA-nanoparticle vaccines
Establish comparative immunogenicity of LAMP modified pp65 and mTERT using DNA based vaccines, RNA electroporated DCs, and RNA-nanoparticle vaccines
|
|
06-2016
|
Reversal of CMV-specific Immune Deficits in Patients with Glioblastoma
Reversal of CMV-specific Immune Deficits in Patients with Glioblastoma
|
|
05-2016
|
Programming Tumor-specific Lymphocytes Targeting Pediatric Brain Tumors
Programming Tumor-specific Lymphocytes Targeting Pediatric Brain Tumors
|
|
07-2015
|
CENTRIC
CENTRIC
|
|
03-2015
|
The Cancer Genome Atlas
The Cancer Genome Atlas
|
|
12-2014
|
CDX110-06
CDX110-06
|
|
11-2014
|
CDX110-04
CDX110-04
|
|
08-2014
|
E1F05
E1F05
|
|
02-2014
|
CDX-110-003
CDX-110-003
|
|
06-2013
|
Shands Housestaff Education Agreement
Shands Housestaff Education Agreement
|
|
06-2013
|
DISBURSEMENT AGREEMENT FOR HOUSESTAFF STIPENDS and FRINGE
DISBURSEMENT AGREEMENT FOR HOUSESTAFF STIPENDS and FRINGE
|
|
12-2012
|
Brain Tumor Registry Program at the McKnight Brain Insti
Brain Tumor Registry Program at the McKnight Brain Insti
|
|
11-2012
|
Brain Tumor Registry Program at the McKnight Brain Insti
Brain Tumor Registry Program at the McKnight Brain Insti
|
|
10-2012
|
Support the Florida Center for Brain Tumor Research
Support the Florida Center for Brain Tumor Research
|
|
06-2012
|
ABCC/FCBTR Supplement
ABCC/FCBTR Supplement
|
|
06-2012
|
IPA for Atchar Sudhyadhom
IPA for Atchar Sudhyadhom
|
|
06-2012
|
Creation of a Radiosurgery Course on Moodle
Creation of a Radiosurgery Course on Moodle
|
|
09-2011
|
TCGA
TCGA
|
|
06-2011
|
Thomas Jefferson University-Lynn Fellowship Support
Thomas Jefferson University-Lynn Fellowship Support
|
|
10-2010
|
FLORIDA CENTER FOR BRAIN TUMOR RESEARCH
FLORIDA CENTER FOR BRAIN TUMOR RESEARCH
|
|
06-2010
|
Shands Housestaff Education Agreement
Shands Housestaff Education Agreement
|
|
06-2010
|
UFRF PROFESSORSHIP
UFRF PROFESSORSHIP
|
|
06-2010
|
UFRF PROFESSORSHIP
UFRF PROFESSORSHIP
|
|
06-2009
|
Shands Housestaff Education Agreement
Shands Housestaff Education Agreement
|
|
06-2008
|
SHANDS HOUSESTAFF EDUCATION AGREEMENT
SHANDS HOUSESTAFF EDUCATION AGREEMENT
|
|
08-2007
|
IMAGE GUIDED SURGERY USING RAPID PROTOTYPING MODELS
IMAGE GUIDED SURGERY USING RAPID PROTOTYPING MODELS
|
|
07-2007
|
US Onyx AVM folow up study
US Onyx AVM folow up study
|
|
06-2006
|
RETURNED ROYALTIES
RETURNED ROYALTIES
|
|
06-2004
|
Balloon Prophylaxis of Aneurysmal Vasospasm(BPAV)
Balloon Prophylaxis of Aneurysmal Vasospasm(BPAV)
|
|
05-2003
|
LINAC STEREOTACTIC RADIOSURGERY FOR THE TREATMENT OF
LINAC STEREOTACTIC RADIOSURGERY FOR THE TREATMENT OF
|
|
01-2000
|
TRIAL OF POLIFEPROSAN 20 WITH CARMUSTINE 3.85% IMPLANT I
TRIAL OF POLIFEPROSAN 20 WITH CARMUSTINE 3.85% IMPLANT I
|